HER2 TARGETING AGENT

The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente inve...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KANEKO Mika, NAKAYAMA Daisuke, KUROGI Masayuki, KATO Yukinari
Format:	Patent
Sprache:	eng ; fre ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	KANEKO Mika NAKAYAMA Daisuke KUROGI Masayuki KATO Yukinari
description	The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente invention concerne : un anticorps ou un fragment de liaison à l'antigène associé qui se lie au HER2, qui est exprimé dans des cellules cancéreuses, ou un fragment du HER2 ; un agent de ciblage du HER2 contenant l'un ou l'autre de ceux-ci ; et une composition pharmaceutique contenant l'agent de ciblage du HER2. 本発明は、がん細胞に発現するＨＥＲ２またはその断片に結合する抗体またはその抗原結合性断片、これらのいずれかを含むＨＥＲ２標的化剤、当該ＨＥＲ２標的化剤を含む医薬組成物を提供する。
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022114163A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022114163A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022114163A13</originalsourceid><addsrcrecordid>eNrjZBDxcA0yUghxDHJ3DfH0c1dwdHf1C-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGhiaGZsaOhsbEqQIA2uwfPA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HER2 TARGETING AGENT</title><source>esp@cenet</source><creator>KANEKO Mika ; NAKAYAMA Daisuke ; KUROGI Masayuki ; KATO Yukinari</creator><creatorcontrib>KANEKO Mika ; NAKAYAMA Daisuke ; KUROGI Masayuki ; KATO Yukinari</creatorcontrib><description>The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente invention concerne : un anticorps ou un fragment de liaison à l'antigène associé qui se lie au HER2, qui est exprimé dans des cellules cancéreuses, ou un fragment du HER2 ; un agent de ciblage du HER2 contenant l'un ou l'autre de ceux-ci ; et une composition pharmaceutique contenant l'agent de ciblage du HER2. 本発明は、がん細胞に発現するＨＥＲ２またはその断片に結合する抗体またはその抗原結合性断片、これらのいずれかを含むＨＥＲ２標的化剤、当該ＨＥＲ２標的化剤を含む医薬組成物を提供する。</description><language>eng ; fre ; jpn</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220602&DB=EPODOC&CC=WO&NR=2022114163A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220602&DB=EPODOC&CC=WO&NR=2022114163A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KANEKO Mika</creatorcontrib><creatorcontrib>NAKAYAMA Daisuke</creatorcontrib><creatorcontrib>KUROGI Masayuki</creatorcontrib><creatorcontrib>KATO Yukinari</creatorcontrib><title>HER2 TARGETING AGENT</title><description>The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente invention concerne : un anticorps ou un fragment de liaison à l'antigène associé qui se lie au HER2, qui est exprimé dans des cellules cancéreuses, ou un fragment du HER2 ; un agent de ciblage du HER2 contenant l'un ou l'autre de ceux-ci ; et une composition pharmaceutique contenant l'agent de ciblage du HER2. 本発明は、がん細胞に発現するＨＥＲ２またはその断片に結合する抗体またはその抗原結合性断片、これらのいずれかを含むＨＥＲ２標的化剤、当該ＨＥＲ２標的化剤を含む医薬組成物を提供する。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDxcA0yUghxDHJ3DfH0c1dwdHf1C-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRkaGhiaGZsaOhsbEqQIA2uwfPA</recordid><startdate>20220602</startdate><enddate>20220602</enddate><creator>KANEKO Mika</creator><creator>NAKAYAMA Daisuke</creator><creator>KUROGI Masayuki</creator><creator>KATO Yukinari</creator><scope>EVB</scope></search><sort><creationdate>20220602</creationdate><title>HER2 TARGETING AGENT</title><author>KANEKO Mika ; NAKAYAMA Daisuke ; KUROGI Masayuki ; KATO Yukinari</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022114163A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>KANEKO Mika</creatorcontrib><creatorcontrib>NAKAYAMA Daisuke</creatorcontrib><creatorcontrib>KUROGI Masayuki</creatorcontrib><creatorcontrib>KATO Yukinari</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KANEKO Mika</au><au>NAKAYAMA Daisuke</au><au>KUROGI Masayuki</au><au>KATO Yukinari</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HER2 TARGETING AGENT</title><date>2022-06-02</date><risdate>2022</risdate><abstract>The present invention provides: an antibody or an antigen-binding fragment thereof which binds to HER2, which is expressed in cancer cells, or a fragment of HER2; a HER2 targeting agent containing either of these; and a pharmaceutical composition containing the HER2 targeting agent. La présente invention concerne : un anticorps ou un fragment de liaison à l'antigène associé qui se lie au HER2, qui est exprimé dans des cellules cancéreuses, ou un fragment du HER2 ; un agent de ciblage du HER2 contenant l'un ou l'autre de ceux-ci ; et une composition pharmaceutique contenant l'agent de ciblage du HER2. 本発明は、がん細胞に発現するＨＥＲ２またはその断片に結合する抗体またはその抗原結合性断片、これらのいずれかを含むＨＥＲ２標的化剤、当該ＨＥＲ２標的化剤を含む医薬組成物を提供する。</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre ; jpn
recordid	cdi_epo_espacenet_WO2022114163A1
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
title	HER2 TARGETING AGENT
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T04%3A33%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KANEKO%20Mika&rft.date=2022-06-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022114163A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true